Nephrogen
Pre-clinicalNephrogen is a preclinical biotech company developing curative genomic medicines for serious diseases. Our initial focus is on kidney and pancreatic diseases, which affect 1 in 5 Americans but are notoriously difficult to treat with genomic medicine because of delivery challenges.
Founded
2009
Focus
RNA & Gene Therapy
About
Nephrogen is a preclinical biotech company developing curative genomic medicines for serious diseases. Our initial focus is on kidney and pancreatic diseases, which affect 1 in 5 Americans but are notoriously difficult to treat with genomic medicine because of delivery challenges.
Company Info
TypePrivate
Founded2009
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile